Related Experiment Video
Updated: May 23, 2025

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
Structure of the human TWIK-2 potassium channel and its inhibition by pimozide
Abstract:
The potassium channel TWIK-2 is crucial for ATP-induced activation of the NLRP3 inflammasome in macrophages. The channel is a member of the two-pore domain potassium (K2P) channel superfamily and an emerging therapeutic target to mitigate severe inflammatory injury involving NLRP3 activation. We report the cryo-EM structure of human TWIK-2. In comparison to other K2P channels, the structure reveals a unique 'up' conformation of Tyr111 in the selectivity filter and a SF1-P1 pocket behind the filter that could serve as a binding site for channel modulators. Density for acyl chains is present in fenestrations within the transmembrane region that connect the central cavity of the pore to the lipid membrane. Limited pharmacological tools are available for TWIK-2 despite its importance as a drug target. We show that the small molecule pimozide inhibits TWIK-2 and determine a structure of the channel with pimozide. Pimozide displaces the acyl chains and binds below the selectivity filter to block ion conduction. The drug may access its binding site via the membrane, suggesting that other hydrophobic small molecules could have utility for inhibiting TWIK-2. The work defines the structure of TWIK-2 and provides a structural foundation for development of specific inhibitors with potential utility as anti-inflammatory drugs.
Significance Statement:
The TWIK-2 potassium channel is a member of the two-pore domain potassium (K2P) channel superfamily and a potential therapeutic target to control severe inflammatory injury involving the NLRP3 inflammasome. We report the cryo-EM structure of the human TWIK-2 channel at 2.85 Å resolution, revealing differences in comparison to other K2P channels. We identify that pimozide, an FDA-approved drug for Tourette syndrome, inhibits TWIK-2. A cryo-EM structure of TWIK-2 in complex with pimozide identifies its binding location and mechanism of inhibition. The work provides a structural foundation for development of specific TWIK-2 inhibitors that have potential therapeutic utility for inflammatory diseases involving NLRP3 activation.
Insights
Researchers determined the cryo-EM structure of the TWIK-2 potassium channel, revealing unique features and a binding site for inhibitors. The drug pimozide was found to inhibit TWIK-2, offering a foundation for new anti-inflammatory therapies.
Area of Science:
- Structural Biology
- Ion Channel Physiology
- Drug Discovery
Background:
- The TWIK-2 potassium channel (a member of the K2P channel superfamily) plays a critical role in NLRP3 inflammasome activation.
- NLRP3 inflammasome activation is implicated in severe inflammatory injuries.
- There is a need for pharmacological tools to modulate TWIK-2 activity.
Purpose of the Study:
- To determine the high-resolution cryo-electron microscopy (cryo-EM) structure of human TWIK-2.
- To identify potential binding sites for small molecule modulators.
- To investigate the inhibitory effect of pimozide on TWIK-2 and elucidate its binding mechanism.
Main Methods:
- Cryo-electron microscopy (cryo-EM) for structure determination.
- Biochemical assays to assess channel inhibition.
- Structural analysis of TWIK-2 and its complex with pimozide.
Main Results:
- The cryo-EM structure of human TWIK-2 revealed unique features, including a specific Tyr111 conformation and an SF1-P1 pocket.
- Acyl chains were observed within fenestrations in the transmembrane region.
- Pimozide was identified as a TWIK-2 inhibitor, binding below the selectivity filter and blocking ion conduction.
- The structure of the TWIK-2-pimozide complex elucidated the drug's binding site and inhibitory mechanism.
Conclusions:
- The determined structure of TWIK-2 provides a foundation for developing specific inhibitors.
- Pimozide's inhibition mechanism suggests that hydrophobic small molecules could be effective TWIK-2 modulators.
- These findings support the development of TWIK-2 inhibitors as potential anti-inflammatory therapeutics for diseases involving NLRP3 activation.
More Related Videos
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Mechanically-gated Ion Channels
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....

